Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026)
Green Thumb Industries (GTBIF) reported Amortization of Deferred Charges of $164000.0 for Q1 2026, up 2.5% on a YoY basis from $160000.0 in Q1 2025, and up 2.5% quarter-over-quarter from $160000.0 in Q4 2025.
Green Thumb Industries (GTBIF) Amortization of Deferred Charges (2019 - 2026) Analysis & Trends
Green Thumb Industries has reported Amortization of Deferred Charges for 8 years, with the latest figure at $164000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization of Deferred Charges rose 2.5% year-over-year to $164000.0; the trailing twelve-month figure through Mar 2026 stood at $643000.0 (down 43.45% YoY), and the FY2025 full-year result was $639000.0, down 79.21% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $164000.0, up from $160000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $2.6 million in Q4 2023, with the low at $61000.0 in Q3 2024.
- Historically, Amortization of Deferred Charges has averaged $1.3 million across 5 years, with a median of $2.1 million in 2024.
- Annual changes were most pronounced in 2024 — Amortization of Deferred Charges sank 97.42% — and 2025, when it soared 162.3%.
- Green Thumb Industries' Amortization of Deferred Charges stood at $2.3 million in 2022, then climbed by 10.83% to $2.6 million in 2023, then sank by 93.82% to $160000.0 in 2024, then changed by 0.0% to $160000.0 in 2025, then increased by 2.5% to $164000.0 in 2026.
- The last three Amortization of Deferred Charges figures came in at $164000.0 (Q1 2026), $160000.0 (Q4 2025), and $160000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.77 Bn | 35.04 Bn | 1.97 Bn |
| 2 | Zoetis | 34.11 Bn | 32.16 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.68 Bn | 21.53 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.48 Bn | 16.40 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.19 Bn | 14.88 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.44 Bn | 11.01 Bn | 785.00 Mn |
| 7 | Alkermes | 7.28 Bn | 6.77 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.48 Bn | 5.98 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.35 Bn | 5.60 Bn | 396.79 Mn |
| 10 | Green Thumb Industries | - | - | 143.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 164,000.00 |
| Mar 31, 2026 | 164,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Dec 31, 2025 | 160,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Sep 30, 2025 | 160,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 159,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Mar 31, 2025 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Dec 31, 2024 | 160,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Sep 30, 2024 | 61,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 2.10 Mn |
| Mar 31, 2024 | 2.10 Mn |
| Dec 31, 2023 | 2.59 Mn |
| Dec 31, 2023 | 2.59 Mn |